Related Experiment Video
Updated: Mar 3, 2026
04:37
Reproductive Techniques for Ovarian Monitoring and Control in Amphibians
Published on: May 12, 2019
16.4K
Ulipristal acetate: An update for Australian GPs
1MD, MBBS, FRACGP, DRANZCOG, GradDipWomsHlth, is Head, Department of General Practice, School of Primary Health Care, Monash University, Victoria.
Australian Family Physician
|May 5, 2017
Summary
Emergency contraception (EC) use is low in Australia. A new ulipristal acetate ECP offers improved options, and general practitioners can play a key role in educating women about emergency contraception.
Area of Science:
- Reproductive Health
- Pharmacology
- General Practice
Background:
- Emergency contraception (EC) use and understanding remain low in Australia, despite the availability of levonorgestrel emergency contraceptive pills (ECPs) for over a decade.
- A novel ECP containing ulipristal acetate was introduced in Australia in April 2016.
Purpose of the Study:
- To enhance understanding of the new ulipristal acetate ECP, covering its safety, efficacy, and specific considerations.
- To address and debunk common myths and misconceptions surrounding emergency contraception.
- To offer guidance on managing emergency contraception within general practice, incorporating recent advancements.
Main Methods:
- Literature review on ulipristal acetate ECP.
- Analysis of safety and efficacy data.
- Guideline development for general practice.
Main Results:
- Ulipristal acetate ECP offers a new option for emergency contraception.
- Understanding of EC varies, with misconceptions prevalent.
- General practitioners (GPs) are a trusted source of information for women regarding EC.
Conclusions:
- General practitioners are well-positioned to improve women's access to and understanding of emergency contraception.
- The introduction of ulipristal acetate ECP presents a significant opportunity for GPs to assist in preventing unplanned pregnancies.
- Empowering GPs with knowledge on EC management can enhance reproductive health outcomes.
More Related Videos
Related Concept Videos
01:21Intrauterine Drug Delivery Systems
62
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
62
01:17Drugs for Treatment of Diarrhea-Predominant IBS
799
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
799
01:22Birth Control Methods
7.1K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
7.1K
01:26FDA Approved Drugs: Changes to Approved Drugs
293
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
293
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
01:21Drugs for Treatment of Constipation-Predominant IBS
1.0K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.0K